Betaville Intelligence

RARE ALERT: Medtronic said to ... - Part 2

Tuesday, 3 March 2020, 5:19 pm

The potential takeover of Intersect ENT by Medtronic may have been delayed following interest from a rival party.

Some people following the situation expected Intersect ENT - which manufactures drug-delivery devices used by Ear, Nose & Throat clinicians in the treatment of sinusitis - to unveil a deal last week but an announcement failed to materialise.

Since then, Intersect ENT's shares have dropped signiticantly amid a wider stockmarket sell off...


Register for free to see rest of this article and all public articles from Betaville

Login / Register

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment